You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

Investigational Drug Information for Laninamivir


✉ Email this page to a colleague

« Back to Dashboard


What is the development status for investigational drug Laninamivir?

Laninamivir is an investigational drug.

There have been 5 clinical trials for Laninamivir. The most recent clinical trial was a Phase 2 trial, which was initiated on May 1st 2013.

The most common disease conditions in clinical trials are Influenza, Human, Asthma, and [disabled in preview]. The leading clinical trial sponsors are Biota Scientific Management Pty Ltd, Department of Health and Human Services, and National Institute of Allergy and Infectious Diseases (NIAID).

Recent Clinical Trials for Laninamivir
TitleSponsorPhase
ADaptive ASsessment of TReatments for influenzA: A Phase 2 Platform Trial of Antiviral Pharmacodynamics in Early Symptomatic InfluenzaUniversity of OxfordPhase 2
Safety & Pharmacokinetics Study of Inhaled Laninamivir Octanoate TwinCaps® Dry Powder Inhaler in Children With InfluenzaDepartment of Health and Human ServicesPhase 1/Phase 2
Safety & Pharmacokinetics Study of Inhaled Laninamivir Octanoate TwinCaps® Dry Powder Inhaler in Children With InfluenzaBiota Scientific Management Pty LtdPhase 1/Phase 2

See all Laninamivir clinical trials

Clinical Trial Summary for Laninamivir

Top disease conditions for Laninamivir
Top clinical trial sponsors for Laninamivir

See all Laninamivir clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.